Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Fluid Management in Chronic Liver Disease

Introduction to Fluid Management

  • The optimal approach to fluid management in chronic liver disease involves dietary sodium restriction, spironolactone as first-line diuretic therapy, with addition of furosemide for refractory cases, and large volume paracentesis with albumin replacement for tense ascites 1, 2, 3

Dietary Management

  • Patients with cirrhosis and ascites should follow a moderately salt-restricted diet with daily salt intake of no more than 5-6.5g, which translates to a no-added salt diet with avoidance of precooked meals 1, 2
  • Nutritional counseling on sodium content in diet is strongly recommended 1, 4
  • Fluid restriction is generally not necessary unless serum sodium is <125 mmol/L 5, 6

Diuretic Therapy

  • For first presentation of moderate ascites, start with spironolactone monotherapy (100mg daily, can be increased up to 400mg) 1, 2
  • For recurrent severe ascites or when faster diuresis is needed, use combination therapy with spironolactone (100-400mg) and furosemide (40-160mg) 1, 4
  • The goal of diuretic therapy is to ensure urinary sodium excretion exceeds 78 mmol/day 7
  • Monitor response using spot urine sodium:potassium ratio; a ratio between 1.8-2.5 predicts adequate sodium excretion 7

Monitoring and Dose Adjustments

  • Monitor for adverse events - almost half of patients require diuretic discontinuation or dose reduction due to complications 2, 4
  • Target weight loss of 0.5kg/day in patients without edema and up to 1kg/day in those with edema 6, 7

Management of Hyponatremia

  • Hypovolaemic hyponatremia (from excessive diuresis): discontinue diuretics and expand plasma volume with normal saline 4, 9
  • Hypervolaemic hyponatremia (more common): restrict fluid to 1-1.5 L/day only if serum sodium <125 mmol/L 4, 6
  • Hypertonic sodium chloride (3%) should be reserved for severely symptomatic patients with acute hyponatremia 3, 4
  • Serum sodium correction should be slow to prevent central pontine myelinolysis 6

Large Volume Paracentesis (LVP)

  • Indicated for tense ascites as initial therapy, followed by sodium restriction and diuretics 5, 10
  • Ultrasound guidance should be considered during LVP to reduce adverse events 2
  • Albumin (20% or 25% solution) should be infused after paracentesis of >5L at a dose of 8g albumin/L of ascites removed 1, 2

Management of Refractory Ascites

  • Defined as ascites unresponsive to sodium restriction and high-dose diuretics (400mg spironolactone and 160mg furosemide) or when complications prevent use of effective doses 8, 10
  • Treatment options include serial therapeutic paracentesis, transjugular intrahepatic portosystemic shunt (TIPSS), or liver transplantation 8, 10
  • TIPSS should be considered in patients with refractory ascites who have relatively preserved liver function 1, 6
  • Midodrine (an α-adrenergic agonist) may be considered on a case-by-case basis for refractory ascites 4, 6

Special Considerations

  • Patients with spontaneous bacterial peritonitis (SBP) and increased or rising serum creatinine should receive albumin infusion (1.5g/kg within 6 hours of diagnosis, followed by 1g/kg on day 3) 2
  • Avoid NSAIDs as they can reduce urinary sodium excretion and convert diuretic-sensitive patients to refractory ones 10